ClinConnect ClinConnect Logo
Search / Trial NCT06886802

Multicentric Case Series of Uniportal Endoscopic Posterior Cervical Decompression for Cervical Spinal Stenosis

Launched by TECSALUD INVESTIGACIÓN CLÍNICA · Mar 13, 2025

Trial Information

Current as of April 29, 2025

Not yet recruiting

Keywords

Cervical Spinal Stenosis ► Minimally Invasive Surgical Procedures ► Endoscopic Spine Surgery ► Spinal Degenerative Disease

ClinConnect Summary

This clinical trial is studying a new surgical technique called Posterior Uniportal Endoscopic Cervical Decompression for patients with cervical spinal stenosis, a condition where the spinal canal narrows and can cause pain, numbness, and weakness. Traditional surgeries can be effective but may come with higher risks and longer recovery times. The goal of this study is to see if this less invasive method can improve symptoms like pain and disability while also being safer and allowing for quicker recovery.

To take part in this trial, patients need to be between 18 and 80 years old and have experienced symptoms from cervical spinal stenosis despite trying conservative treatments like physical therapy for at least three months. Participants will undergo this new surgical procedure, which involves a small incision to relieve pressure on the nerves. Throughout the study, researchers will follow up with patients for a year to measure improvements in their symptoms and document any complications. This research could help support the use of this innovative technique as a promising option for treating cervical spinal stenosis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provision of informed consent to participate in the study.
  • Patients with cervical canal stenosis grade I-III according to the Kang scale.
  • Radicular or myelopathic symptoms.
  • Having undergone complete conservative management, including physical therapy and analgesia, for at least 3 months.
  • Patients who have opted for posterior uniportal endoscopic cervical decompression for cervical canal stenosis.
  • Exclusion Criteria:
  • Inability to read or write.
  • Prior cervical surgeries at the levels to be treated.
  • Infectious symptoms or concomitant rheumatologic diseases.
  • Criteria of cervical vertebral instability.
  • Congenital spinal malformations.
  • Disc herniation at the same cervical level to be operated on.
  • Medullary hyperintensity on T2-weighted magnetic resonance imaging in the level(s) to be treated.

About Tecsalud Investigación Clínica

Tecsalud Investigación Clínica is a leading clinical research organization dedicated to advancing medical science through innovative and ethical research practices. With a strong commitment to improving patient outcomes, Tecsalud specializes in conducting Phase I-IV clinical trials across various therapeutic areas. The organization collaborates with pharmaceutical and biotechnology companies to facilitate the development of new therapies, ensuring compliance with regulatory standards and upholding the highest quality in research. Through a multidisciplinary team of experienced professionals, Tecsalud strives to enhance the efficiency of clinical trials while prioritizing participant safety and well-being.

Locations

San Pedro Garza García, Nuevo León, Mexico

Patients applied

0 patients applied

Trial Officials

Mario Benvenutti Regato, MD

Principal Investigator

TecSalud

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported